Medpace Holdings (MEDP) Gross Margin (2015 - 2026)

Medpace Holdings (MEDP) has reported Gross Margin for 12 consecutive years, with 28.51% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin fell 133.0% year-over-year to 28.51%; the trailing twelve-month figure through Jun 2026 stood at 28.76% (down 286.0% YoY), and the FY2025 full-year result was 30.06%, down 106.0% from the prior year.
• Gross Margin grew to 28.51% in Q2 2026 per MEDP's latest filing, from 27.78% in the prior quarter.
• Across five years, Gross Margin topped out at 33.23% in Q4 2024 and bottomed at 26.97% in Q2 2023.
• Historically, Gross Margin has averaged 29.51% across 5 years, with a median of 29.59% in 2022.
• The sharpest annual moves came in 2024 and 2025: Gross Margin jumped 578 bps in 2024, then plunged 425 bps in 2025.
• Over 5 years, Gross Margin stood at 29.37% in 2022, then dropped by 7 bps to 27.45% in 2023, then climbed by 21 bps to 33.23% in 2024, then retreated by 13 bps to 28.98% in 2025, then retreated by 2 bps to 28.51% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 28.51%, 27.78%, and 28.98% for Q2 2026, Q1 2026, and Q4 2025 respectively.